[go: up one dir, main page]

HUP0104273A2 - Szemiszintetikus ecteinascidinek és ezeket tartalmazó gyógyászati készítmények - Google Patents

Szemiszintetikus ecteinascidinek és ezeket tartalmazó gyógyászati készítmények

Info

Publication number
HUP0104273A2
HUP0104273A2 HU0104273A HUP0104273A HUP0104273A2 HU P0104273 A2 HUP0104273 A2 HU P0104273A2 HU 0104273 A HU0104273 A HU 0104273A HU P0104273 A HUP0104273 A HU P0104273A HU P0104273 A2 HUP0104273 A2 HU P0104273A2
Authority
HU
Hungary
Prior art keywords
semi
pharmaceutical compositions
compositions containing
synthetic
ecteinascidins
Prior art date
Application number
HU0104273A
Other languages
English (en)
Inventor
Jose J. Morales
Kenneth L. Rinehart
Original Assignee
The Board Of Trustees Of The University Of Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Board Of Trustees Of The University Of Illinois filed Critical The Board Of Trustees Of The University Of Illinois
Publication of HUP0104273A2 publication Critical patent/HUP0104273A2/hu
Publication of HUP0104273A3 publication Critical patent/HUP0104273A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Dental Preparations (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

A találmány számos új szemiszintetikus ecteinascidin- (Et)származékra, éspedig az itt Et 757, Boc-Et 729, Izo-Et 743, Et 875 ésEt 1560 jelölésekkel jelzett, rendre az (I), (II), (III), (IV) és (V)képlettel jelölt származékokra, valamint ezeket tartalmazó gyógyászatikészítményekre és ezek tumorellenes alkalmazására vonatkozik. Ó
HU0104273A 1998-04-06 1999-04-05 Semi-synthetic ecteinascidins and pharmaceutical compositions containing them HUP0104273A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8080298P 1998-04-06 1998-04-06
PCT/US1999/007471 WO1999051238A1 (en) 1998-04-06 1999-04-05 Semi-synthetic ecteinascidins

Publications (2)

Publication Number Publication Date
HUP0104273A2 true HUP0104273A2 (hu) 2002-03-28
HUP0104273A3 HUP0104273A3 (en) 2003-12-29

Family

ID=22159716

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104273A HUP0104273A3 (en) 1998-04-06 1999-04-05 Semi-synthetic ecteinascidins and pharmaceutical compositions containing them

Country Status (28)

Country Link
US (1) US6124293A (hu)
EP (2) EP1067933B1 (hu)
JP (1) JP4443043B2 (hu)
KR (1) KR100603219B1 (hu)
CN (1) CN1157189C (hu)
AT (1) ATE370148T1 (hu)
AU (1) AU758100B2 (hu)
BG (1) BG65088B1 (hu)
BR (1) BR9909488B1 (hu)
CA (1) CA2327468C (hu)
CY (1) CY1106988T1 (hu)
CZ (1) CZ301083B6 (hu)
DE (1) DE69936845T2 (hu)
DK (1) DK1067933T3 (hu)
ES (1) ES2292237T3 (hu)
HK (1) HK1033651A1 (hu)
HU (1) HUP0104273A3 (hu)
IL (2) IL138856A0 (hu)
MX (1) MXPA00009840A (hu)
NO (1) NO328147B1 (hu)
NZ (1) NZ507350A (hu)
PL (1) PL196809B1 (hu)
PT (1) PT1067933E (hu)
RU (1) RU2217432C2 (hu)
SK (1) SK285669B6 (hu)
TR (1) TR200002921T2 (hu)
UA (1) UA59439C2 (hu)
WO (1) WO1999051238A1 (hu)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985876A (en) * 1997-04-15 1999-11-16 Univ Illinois Nucleophile substituted ecteinascidins and N-oxide ecteinascidins
CA2331593C (en) * 1998-05-11 2008-08-05 Pharma Mar, S.A. Metabolites of ecteinascidin 743
MY164077A (en) * 1999-05-13 2017-11-30 Pharma Mar Sa Compositions and uses of et743 for treating cancer
AR035842A1 (es) * 1999-05-14 2004-07-21 Pharma Mar Sa Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo
EP1254140A4 (en) 2000-01-19 2003-03-12 Univ Columbia SAFRAMYCIN-ECTEINASCIDIN SERIES COMPOUNDS, USES AND SYNTHESIS
US7919493B2 (en) * 2000-04-12 2011-04-05 Pharma Mar, S.A. Anititumoral ecteinascidin derivatives
MXPA02011319A (es) * 2000-05-15 2003-06-06 Pharma Mar Sa Analogos antitumorales de ecteinascidina 743.
AU2002239565B2 (en) * 2000-11-03 2007-11-15 President And Fellows Of Harvard College Saframycins, analogues and uses thereof
WO2002036135A2 (en) * 2000-11-06 2002-05-10 Pharma Mar, S.A. Compositions for antitumour treatment containing ecteinascidin 743
GB0117402D0 (en) * 2001-07-17 2001-09-05 Pharma Mar Sa New antitumoral derivatives of et-743
GB0119243D0 (en) 2001-08-07 2001-10-03 Pharma Mar Sa Antitumoral analogs of ET-743
GB0202544D0 (en) 2002-02-04 2002-03-20 Pharma Mar Sa The synthesis of naturally occuring ecteinascidins and related compounds
GB0312407D0 (en) * 2003-05-29 2003-07-02 Pharma Mar Sau Treatment
GB0324201D0 (en) * 2003-10-15 2003-11-19 Pharma Mar Sau Improved antitumoral combinations
WO2005049031A1 (en) 2003-11-13 2005-06-02 Pharma Mar, S.A.U. Combination
GB0326486D0 (en) * 2003-11-14 2003-12-17 Pharma Mar Sau Combination treatment
US20080255132A1 (en) * 2003-11-14 2008-10-16 Eric Rowinsky Combination Therapy Comprising the Use of Et-743 and Paclitaxel for Treating Cancer
WO2006005602A2 (en) * 2004-07-09 2006-01-19 Pharma Mar, S.A. Use of ecteinascidin in the treatment of cancer in patients with low level of brca1
AU2005288696A1 (en) * 2004-09-28 2006-04-06 Pharma Mar S.A., Sociedad Unipersonal Ecteinascidin compounds as anti -inflammatory agents
DE602005014380D1 (de) * 2004-10-26 2009-06-18 Ortho Biotech Products L P Pegyliertes liposomales doxorubicin in kombination mit ecteinescidin 743
DK1658848T3 (da) 2004-10-29 2007-11-26 Pharma Mar Sa Formuleringer omfattende ecteinascidin og et disaccharid
GB0522082D0 (en) * 2005-10-31 2005-12-07 Pharma Mar Sa Formulations
CN100355775C (zh) * 2006-01-20 2007-12-19 南方医科大学 一种海鞘多肽及其制备方法
WO2009050303A1 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Prognostic molecular markers for et-743 treatment
RU2605335C2 (ru) 2010-11-12 2016-12-20 Фарма Мар, С.А. Комбинированная терапия противоопухолевым алкалоидом
CA3011527A1 (en) * 2016-02-04 2017-08-10 Jiangsu Hengrui Medicine Co., Ltd. Trabectedin-inclusive injectable pharmaceutical composition for gastrointestinal external use and method for manufacturing the same
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256663A (en) * 1986-06-09 1993-10-26 The Board Of Trustees Of The University Of Illinois Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
US5149804A (en) * 1990-11-30 1992-09-22 The Board Of Trustees Of The University Of Illinois Ecteinascidins 736 and 722
US5089273A (en) * 1986-06-09 1992-02-18 Board Of Trustees Of The University Of Illinois Ecteinascidins 729, 743, 745, 759A, 759B and 770
US5440055A (en) * 1993-03-12 1995-08-08 Aphios Corporation Method and apparatus for extracting taxol from source materials
US5478932A (en) * 1993-12-02 1995-12-26 The Board Of Trustees Of The University Of Illinois Ecteinascidins
US5721362A (en) * 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds

Also Published As

Publication number Publication date
RU2000128058A (ru) 2004-02-20
KR100603219B1 (ko) 2006-07-20
NZ507350A (en) 2003-03-28
IL138856A0 (en) 2001-10-31
HUP0104273A3 (en) 2003-12-29
BG104902A (en) 2001-07-31
JP4443043B2 (ja) 2010-03-31
EP1876180A3 (en) 2009-12-16
PL196809B1 (pl) 2008-02-29
IL138856A (en) 2007-07-24
JP2002510633A (ja) 2002-04-09
SK285669B6 (sk) 2007-06-07
RU2217432C2 (ru) 2003-11-27
CZ20003650A3 (en) 2001-06-13
TR200002921T2 (tr) 2001-02-21
CY1106988T1 (el) 2012-09-26
NO328147B1 (no) 2009-12-21
AU3471399A (en) 1999-10-25
BR9909488A (pt) 2000-12-26
WO1999051238A9 (en) 2000-01-27
KR20010074474A (ko) 2001-08-04
ES2292237T3 (es) 2008-03-01
NO20004978L (no) 2000-12-05
CZ301083B6 (cs) 2009-11-04
DE69936845D1 (de) 2007-09-27
EP1067933A4 (en) 2002-12-18
PT1067933E (pt) 2007-11-15
EP1067933A1 (en) 2001-01-17
AU758100B2 (en) 2003-03-13
MXPA00009840A (es) 2002-04-24
CN1304309A (zh) 2001-07-18
CN1157189C (zh) 2004-07-14
CA2327468C (en) 2008-05-06
CA2327468A1 (en) 1999-10-14
SK15012000A3 (sk) 2001-08-06
NO20004978D0 (no) 2000-10-03
BG65088B1 (bg) 2007-02-28
BR9909488B1 (pt) 2011-02-08
HK1033651A1 (en) 2001-09-14
UA59439C2 (uk) 2003-09-15
US6124293A (en) 2000-09-26
EP1067933B1 (en) 2007-08-15
WO1999051238A1 (en) 1999-10-14
DE69936845T2 (de) 2008-05-08
PL343439A1 (en) 2001-08-13
EP1876180A2 (en) 2008-01-09
ATE370148T1 (de) 2007-09-15
DK1067933T3 (da) 2007-12-27

Similar Documents

Publication Publication Date Title
HUP0104273A2 (hu) Szemiszintetikus ecteinascidinek és ezeket tartalmazó gyógyászati készítmények
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
FR2601675B1 (fr) Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
NO943002L (no) Fosfono-oksymetyletere av taxanderivater
HUP0100949A2 (hu) Aril kondenzált azapoliciklusos vegyületek és ezeket tartalmazó gyógyászati készítmények
DE69940674D1 (de) Orale verabreichung von adenosin analogen
FI952920A0 (fi) 7-halogeeni- ja 7beta,8beta-metano-taksolit, niiden antineoplastinen käyttö ja niitä sisältävät farmaseuttiset koostumukset
NO990789D0 (no) Cytotoksisk aminosukker og beslektede sukker-derivater av indolopyrrolokarbazoler
HUP0101293A2 (hu) AspB28-humán inzulint tartalmazó inhalációs gyógyászati készítmény és alkalmazása
TR200101412T2 (tr) Yeni bileşikler.
HUP0103590A2 (hu) Nukleofilszubsztitutált ekteinaszcidinek és N-oxid-ekteinaszcidinek, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
HUP0101960A2 (hu) Az ekteinaszcidin 743 metabolitjai, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
FI895520A0 (fi) Anti-aterosklerotiska diaryl foereningar.
ES2181824T3 (es) Profarmacos de derivados de paclitaxel.
AR029509A1 (es) Una composicion farmaceutica en base a un compuesto de platino (iv) y el uso de dicho compuesto para preparar medicamentos antitumorales
HUP0200055A2 (hu) 16-Hidroxi-ösztratriének és ezeket tartalmazó gyógyszerkészítmények
NO20006230L (no) Hyperforinderivater, anvendelsen derav og formuleringer inneholdende dem
HUP9801068A2 (hu) 1,2,3,4-Tetrahidro-2-naftil-amin-származékok, ezek előállítása és alkalmazása, valamint ilyen származékokat tartalmazó gyógyászati készítmények
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
HUP9903619A2 (hu) 5HT2c Antagonistát és D2 antagonistát tartalmazó gyógyszerkészítmény
HUP0003429A1 (hu) Kamptotecin optikailag tiszta analógjai, és az azokat tartalmazó gyógyszerkészítmények, optikailag tiszta szintetikus közbenső termékek és eljárás azok előállítására
ES466057A1 (es) Un procedimiento para preparar compuestos de 4"-desoxi-4"- amino-eritromicina a.
NZ217356A (en) Benzamide derivatives and pharmaceutical compositions
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees